Route 92 Medical

About Route 92 Medical, Inc. Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design.

Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to treat challenging diseases such as stroke.

Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the world’s leading clinicians with the goal of improving procedural and patient outcomes. The Monopoint operating platform received U.S.

FDA 510(k) clearance in 2020. The company is currently enrolling the SUMMIT MAX randomized controlled trial under an FDA-approved Investigational Device Exemption.